Roles of TGF‑β signalling pathway‑related lncRNAs in cancer (Review)
- Authors:
- Zhizhong Hu
- Yitong Liu
- Meiqi Liu
- Yang Zhang
- Chengkun Wang
-
Affiliations: Cancer Research Institute, Medical School, University of South China, Hengyang, Hunan 421001, P.R. China - Published online on: February 2, 2023 https://doi.org/10.3892/ol.2023.13693
- Article Number: 107
-
Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Dahariya S, Paddibhatla I, Kumar S, Raghuwanshi S, Pallepati A and Gutti RK: Long non-coding RNA: Classification, biogenesis and functions in blood cells. Mol Immunol. 112:82–92. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Chen Z, Wang X, Huang Z, He Z and Chen Y: Long non-coding RNA: A new player in cancer. J Hematol Oncol. 6:372013. View Article : Google Scholar : PubMed/NCBI | |
|
Bhat AA, Younes SN, Raza SS, Zarif L, Nisar S, Ahmed I, Mir R, Kumar S, Sharawat SK, Hashem S, et al: Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. Mol Cancer. 19:572020. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Y, Qiu M, Shen M, Dong S, Ye G, Shi X and Sun M: The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism. Mol Ther. 29:2209–2218. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu D, Shi C, Jiang Y, Zhu K, Wang X and Feng W: Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21. Bioengineered. 12:1505–1516. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Colak S and Ten Dijke P: Targeting TGF-β signaling in cancer. Trends Cancer. 3:56–71. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ikushima H and Miyazono K: TGF-β signal transduction spreading to a wider field: A broad variety of mechanisms for context-dependent effects of TGF-β. Cell Tissue Res. 347:37–49. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao M, Mishra L and Deng CX: The role of TGF-β/SMAD4 signaling in cancer. Int J Biol Sci. 14:111–123. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang C, Hao Y, Wang Y, Xu J, Teng Y and Yang X: TGF-β/SMAD4-regulated LncRNA-LINP1 inhibits epithelial-mesenchymal transition in lung cancer. Int J Biol Sci. 14:1715–1723. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Z, Chen Z, Li Y, Wang J, Zhang Z, Che Y, Huang J, Sun S, Mao S, Lei Y, et al: TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling. J Mol Med (Berl). 96:301–313. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Shen X, Hu X, Mao J, Wu Y, Liu H, Shen J, Yu J and Chen W: The long noncoding RNA TUG1 is required for TGF-β/TWIST1/EMT-mediated metastasis in colorectal cancer cells. Cell Death Dis. 11:652020. View Article : Google Scholar : PubMed/NCBI | |
|
Tan YT, Lin JF, Li T, Li JJ, Xu RH and Ju HQ: LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond). 41:109–120. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou B, Yang H, Yang C, Bao YL, Yang SM, Liu J and Xiao YF: Translation of noncoding RNAs and cancer. Cancer Lett. 497:89–99. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Peng WX, Koirala P and Mo YY: LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Brannan CI, Dees EC, Ingram RS and Tilghman SM: The product of the H19 gene may function as an RNA. Mol Cell Biol. 10:28–36. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Kwok ZH and Tay Y: Long noncoding RNAs: Lincs between human health and disease. Biochem Soc Trans. 45:805–812. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kong X, Duan Y, Sang Y, Li Y, Zhang H, Liang Y, Liu Y, Zhang N and Yang Q: LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol. 234:9105–9117. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Takeiwa T, Mitobe Y, Ikeda K, Hasegawa K, Horie K and Inoue S: Long intergenic noncoding RNA promotes ovarian cancer growth by modulating apoptosis-related gene expression. Int J Mol Sci. 22:112422021. View Article : Google Scholar : PubMed/NCBI | |
|
Huang R, Nie W, Yao K and Chou J: Depletion of the lncRNA RP11-567G11.1 inhibits pancreatic cancer progression. Biomed Pharmacother. 112:1086852019. View Article : Google Scholar : PubMed/NCBI | |
|
Xu K, Cai Y, Zhang M, Zou H, Chang Z, Li D, Bai J, Xu J and Li Y: Pan-cancer characterization of expression and clinical relevance of m6A-related tissue-elevated long non-coding RNAs. Mol Cancer. 20:312021. View Article : Google Scholar : PubMed/NCBI | |
|
Lin J, Liao S, Liu Z, Li E, Wu X and Zeng W: LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis. Cancer Biol Ther. 22:257–266. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Sun H, Sun X, Zhang H, Yue A and Sun M: LncRNA-PCAT1 controls the growth, metastasis and drug resistance of human colon cancer cells. J BUON. 25:2180–2185. 2020.PubMed/NCBI | |
|
Shang C, Wang W, Liao Y, Chen Y, Liu T, Du Q, Huang J, Liang Y, Liu J, Zhao Y, et al: LNMICC promotes nodal metastasis of cervical cancer by reprogramming fatty acid metabolism. Cancer Re. 78:877–890. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bhan A, Soleimani M and Mandal SS: Long noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ransohoff JD, Wei Y and Khavari PA: The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol. 19:143–157. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wei GH and Wang X: lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway. Eur Rev Med Pharmacol Sci. 21:3850–3856. 2017.PubMed/NCBI | |
|
Hu W, Wang Z, Li Q, Wang J, Li L and Jiang G: Upregulation of lincRNA-p21 in thoracic aortic aneurysms is involved in the regulation of proliferation and apoptosis of vascular smooth muscle cells by activating TGF-β1 signaling pathway. J Cell Biochem. 120:4113–4120. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Han M, Liao Z, Liu F, Chen X and Zhang B: Modulation of the TGF-β signaling pathway by long noncoding RNA in hepatocellular carcinoma. Biomark Res. 8:702020. View Article : Google Scholar : PubMed/NCBI | |
|
Goyal B, Yadav SRM, Awasthee N, Gupta S, Kunnumakkara AB and Gupta SC: Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer. Biochim Biophys Acta Rev Cancer. 1875:1885022021. View Article : Google Scholar : PubMed/NCBI | |
|
Morikawa M, Derynck R and Miyazono K: TGF-β and the TGF-β Family: Context-dependent roles in cell and tissue physiology. Cold Spring Harb Perspect Biol. 8:a0218732016. View Article : Google Scholar : PubMed/NCBI | |
|
Heldin CH and Moustakas A: Signaling receptors for TGF-β family members. Cold Spring Harb Perspect Biol. 8:a0220532016. View Article : Google Scholar : PubMed/NCBI | |
|
Syed V: TGF-β signaling in cancer. J Cell Biochem. 117:1279–1287. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wrana JL, Attisano L, Wieser R, Ventura F and Massagué J: Mechanism of activation of the TGF-beta receptor. Nature. 370:341–347. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Lan HY: Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int J Biol Sci. 7:1056–1067. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Attisano L and Wrana JL: Smads as transcriptional co-modulators. Curr Opin Cell Biol. 12:235–243. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Miyazawa K and Miyazono K: Regulation of TGF-β family signaling by inhibitory smads. Cold Spring Harb Perspect Biol. 9:a0220952017. View Article : Google Scholar : PubMed/NCBI | |
|
Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH and Wrana JL: Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell. 6:1365–1375. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T and Miyazono K: Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem. 276:12477–12480. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Ogunjimi AA, Briant DJ, Pece-Barbara N, Le Roy C, Di Guglielmo GM, Kavsak P, Rasmussen RK, Seet BT, Sicheri F and Wrana JL: Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol Cell. 19:297–308. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Komuro A, Imamura T, Saitoh M, Yoshida Y, Yamori T, Miyazono K and Miyazawa K: Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1). Oncogene. 23:6914–6923. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Alexander PB and Wang XF: TGF-β family signaling in the control of cell proliferation and survival. Cold Spring Harb Perspect Biol. 9:a0221452017. View Article : Google Scholar : PubMed/NCBI | |
|
Peng D, Fu M, Wang M, Wei Y and Wei X: Targeting TGF-β signal transduction for fibrosis and cancer therapy. Molecular Cancer. 21:1042022. View Article : Google Scholar : PubMed/NCBI | |
|
Moustakas A and Heldin CH: Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 98:1512–1520. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Xie F, Ling L, van Dam H, Zhou F and Zhang L: TGF-β signaling in cancer metastasis. Acta Biochim Biophys Sin (Shanghai). 50:121–132. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ma S, Li X, Wang X, Cheng L, Li Z, Zhang C, Ye Z and Qian Q: Current progress in CAR-T cell therapy for solid tumors. Int J Biol Sci. 15:2548–2560. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Shen X and Zhao B: Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: Meta-analysis. BMJ. 362:k35292018. View Article : Google Scholar : PubMed/NCBI | |
|
Biller LH and Schrag D: Diagnosis and treatment of metastatic colorectal cancer: A review. JAMA. 325:669–685. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Harada S and Morlote D: Molecular pathology of colorectal cancer. Adv Anat Pathol. 27:20–26. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wu N, Jiang M, Liu H, Chu Y, Wang D, Cao J, Wang Z, Xie X, Han Y and Xu B: LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-β/SMAD2/3 signaling pathway. Cell Death Differ. 28:219–232. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Schwarzmueller L, Bril O, Vermeulen L and Léveillé N: Emerging role and therapeutic potential of lncRNAs in colorectal cancer. Cancers (Basel). 12:38432020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Lai Q, He J, Li Q, Ding J, Lan Z, Gu C, Yan Q, Fang Y, Zhao X and Liu S: LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-beta/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Int J Med Sci. 16:51–59. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Javanmard AR, Dokanehiifard S, Bohlooli M and Soltani BM: LOC646329 long non-coding RNA sponges miR-29b-1 and regulates TGFβ signaling in colorectal cancer. J Cancer Res Clin Oncol. 146:1205–1215. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhan J, Tong J and Fu Q: Long non-coding RNA LINC00858 promotes TP53-wild-type colorectal cancer progression by regulating the microRNA-25-3p/SMAD7 axis. Oncol Rep. 43:1267–1277. 2020.PubMed/NCBI | |
|
Li Q, Yue W, Li M, Jiang Z, Hou Z, Liu W, Ma N, Gan W, Li Y, Zhou T, et al: Downregulating Long Non-coding RNAs CTBP1-AS2 inhibits colorectal cancer development by modulating the miR-93-5p/TGF-β/SMAD2/3 pathway. Front Oncol. 11:6266202021. View Article : Google Scholar : PubMed/NCBI | |
|
Luo K, Geng J, Zhang Q, Xu Y, Zhou X, Huang Z, Shi KQ, Pan C and Wu J: LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer. J Exp Clin Cancer Res. 38:2492019. View Article : Google Scholar : PubMed/NCBI | |
|
Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A and Roberts LR: A global view of hepatocellular carcinoma: Trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 16:589–604. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Laube R, Sabih AH, Strasser SI, Lim L, Cigolini M and Liu K: Palliative care in hepatocellular carcinoma. J Gastroenterol Hepatol. 36:618–628. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Huang WJ, Tian XP, Bi SX, Zhang SR, He TS, Song LY, Yun JP, Zhou ZG, Yu RM and Li M: The β-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis. Oncogene. 39:4538–4550. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wu YH, Yu B, Chen WX, Ai X, Zhang W, Dong W and Shao YJ: Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway. Aging (Albany NY). 13:19260–19271. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Liu G, Li X, Dong H, Xiao W and Lu S: Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Biochem Biophys Res Commun. 503:2826–2832. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Guo D, Ren M, Zhao Y, Wang X, Chen Y, Liu Y, Lu G and He S: Long non-coding RNA SNAI3-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the UPF1/Smad7 signalling pathway. J Cell Mol Med. 23:6271–6282. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yang X, Cai JB, Peng R, Wei CY, Lu JC, Gao C, Shen ZZ, Zhang PF, Huang XY, Ke AW, et al: The long noncoding RNA NORAD enhances the TGF-β pathway to promote hepatocellular carcinoma progression by targeting miR-202-5p. J Cell Physiol. 234:12051–12060. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hu ML, Wang XY and Chen WM: TGF-β1 upregulates the expression of lncRNA UCA1 and its downstream HXK2 to promote the growth of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 22:4846–4854. 2018.PubMed/NCBI | |
|
Dong H, Zhang Y, Xu Y, Ma R, Liu L, Luo C and Jiang W: Downregulation of long non-coding RNA MEG3 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by upregulating TGF-β1. Acta Biochim Biophys Sin (Shanghai). 51:645–652. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Z, Xiang L, Li L, Ou H, Fang Y, Xu Y, Liu Q, Hu Z, Huang Y, Li X and Yang D: TGF-β1 induced deficiency of linc00261 promotes epithelial-mesenchymal-transition and stemness of hepatocellular carcinoma via modulating SMAD3. J Transl Med. 20:752022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Niu H, Ma J, Yuan BY, Chen YH, Zhuang Y, Chen GW, Zeng ZC and Xiang ZL: The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma. Mol Cancer. 18:1202019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Yang L, Dong X, Yang X, Zhang X, Liu Z, Zhao X and Wen T: Overexpression of NNT-AS1 activates TGF-β signaling to decrease tumor CD4 lymphocyte infiltration in hepatocellular carcinoma. Biomed Res Int. 2020:82165412020. View Article : Google Scholar : PubMed/NCBI | |
|
Tayob N, Kanwal F, Alsarraj A, Hernaez R and El-Serag HB: The performance of AFP, AFP-3, DCP as biomarkers for detection of hepatocellular carcinoma (HCC): A Phase 3 Biomarker Study in the United States. Clin Gastroenterol Hepatol. Feb 3–2022.doi: 10.1016/j.cgh.2022.01.047 (Epub ahead of print). | |
|
Smyth EC, Nilsson M, Grabsch HI, van Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Thrift AP and El-Serag HB: Burden of gastric cancer. Clin Gastroenterol Hepatol. 18:534–542. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X and Wu J: LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-β pathway in gastric cancer. Pathol Res Pract. 224:1534922021. View Article : Google Scholar : PubMed/NCBI | |
|
Fu M, Huang Z, Zang X, Pan L, Liang W, Chen J, Qian H, Xu W, Jiang P and Zhang X: Long noncoding RNA LINC00978 promotes cancer growth and acts as a diagnostic biomarker in gastric cancer. Cell Prolif. 51:e124252018. View Article : Google Scholar : PubMed/NCBI | |
|
Moreau JM, Velegraki M, Bolyard C, Rosenblum MD and Li Z: Transforming growth factor-β1 in regulatory T cell biology. Sci Immunol. 7:eabi46132022. View Article : Google Scholar : PubMed/NCBI | |
|
Xiong G, Yang L, Chen Y and Fan Z: Linc-POU3F3 promotes cell proliferation in gastric cancer via increasing T-reg distribution. Am J Transl Res. 7:2262–2269. 2015.PubMed/NCBI | |
|
Huang D, Zhang K, Zheng W, Zhang R, Chen J, Du N, Xia Y, Long Y, Gu Y, Xu J and Deng M: Long noncoding RNA SGO1-AS1 inactivates TGFβ signaling by facilitating TGFB1/2 mRNA decay and inhibits gastric carcinoma metastasis. J Exp Clin Cancer Res. 40:3422021. View Article : Google Scholar : PubMed/NCBI | |
|
Sakai S, Ohhata T, Kitagawa K, Uchida C, Aoshima T, Niida H, Suzuki T, Inoue Y, Miyazawa K and Kitagawa M: Long Noncoding RNA ELIT-1 Acts as a Smad3 cofactor to facilitate TGFβ/Smad signaling and promote epithelial-mesenchymal transition. Cancer Res. 79:2821–2838. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Su J, Chen D, Ruan Y, Tian Y, Lv K, Zhou X, Ying D and Lu Y: LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-β pathway by modulating miR-424-5p/Smad7 axis. Bioengineered. 13:6978–6995. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Wang M, Zhou H, Lu S and Zhang B: Long Noncoding RNA EBLN3P promotes the progression of liver cancer via alteration of microRNA-144-3p/DOCK4 signal. Cancer Manag Res. 12:9339–9349. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Fahad Ullah M: Breast cancer: Current perspectives on the disease status. Adv Exp Med Biol. 1152:51–64. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Januškevičienė I and Petrikaitė V: Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations. Life Sci. 239:1170092019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Zhu M, Sun Y, Li W, Wang Y and Yu W: Upregulation of lncRNA CASC2 suppresses cell proliferation and metastasis of breast cancer via inactivation of the TGF-β signaling pathway. Oncol Res. 27:379–387. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wu ZJ, Li Y, Wu YZ, Wang Y, Nian WQ, Wang LL, Li LC, Luo HL and Wang DL: Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway. Eur Rev Med Pharmacol Sci. 21:706–714. 2017.PubMed/NCBI | |
|
Hou L, Tu J, Cheng F, Yang H, Yu F, Wang M, Liu J, Fan J and Zhou G: Long noncoding RNA ROR promotes breast cancer by regulating the TGF-β pathway. Cancer Cell International. 18:1422018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang CL, Li JC, Zhou CX, Ma CN, Wang DF, Wo LL, He M, Yin Q, He JR and Zhao Q: Long non-coding RNA ARHGAP5-AS1 inhibits migration of breast cancer cell via stabilizing SMAD7 protein. Breast Cancer Res Treat. 189:607–619. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ni K, Huang Z, Zhu Y, Xue D, Jin Q, Zhang C and Gu C: The lncRNA ADAMTS9-AS2 regulates RPL22 to modulate TNBC progression controlling the TGF-β signaling pathway. Front Oncol. 11:6544722021. View Article : Google Scholar : PubMed/NCBI | |
|
Mota MSV, Jackson WP, Bailey SK, Vayalil P, Landar A, Rostas JW III, Mulekar MS, Samant RS and Shevde LA: Deficiency of tumor suppressor Merlin facilitates metabolic adaptation by co-operative engagement of SMAD–Hippo signaling in breast cancer. Carcinogenesis. 39:1165–1175. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bo H, Zhang W, Zhong X, Chen J, Liu Y, Cheong KL, Fan R and Tang S: LINC00467, driven by copy number amplification and DNA demethylation, is associated with oxidative lipid metabolism and immune infiltration in breast cancer. Oxid Med Cell Longev. 2021:45863192021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Wang M, Sun H, Zhu T and Wang X: Downregulation of LINC00894-002 contributes to tamoxifen resistance by enhancing the TGF-β signaling pathway. Biochemistry (Mosc). 83:603–611. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tang L, Chen Y, Chen H, Jiang P, Yan L, Mo D, Tang X and Yan F: DCST1-AS1 Promotes TGF-β-induced epithelial-mesenchymal transition and enhances chemoresistance in triple-negative breast cancer cells via ANXA1. Front Oncol. 10:2802020. View Article : Google Scholar : PubMed/NCBI | |
|
Ren Y, Jia HH, Xu YQ, Zhou X, Zhao XH, Wang YF, Song X, Zhu ZY, Sun T, Dou Y, et al: Paracrine and epigenetic control of CAF-induced metastasis: The role of HOTAIR stimulated by TGF-ß1 secretion. Mol Cancer. 17:52018. View Article : Google Scholar : PubMed/NCBI | |
|
Toumazis I, Bastani M, Han SS and Plevritis SK: Risk-based lung cancer screening: A systematic review. Lung Cancer. 147:154–186. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Nooreldeen R and Bach H: Current and future development in lung cancer diagnosis. Int J Mol Sci. 22:86612021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S, Lan F and Xia Y: lncRA ANCR inhibits non-small cell lung cancer cell migration and invasion by inactivating TGF-β pathway. Med Sci Monit. 24:6002–6009. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Su WZ and Yuan X: LncRNA GASL1 inhibits tumor growth of non-small cell lung cancer by inactivating TGF-β pathway. Eur Rev Med Pharmacol Sci. 22:7282–7288. 2018.PubMed/NCBI | |
|
Lu Z, Li Y, Wang J, Che Y, Sun S, Huang J, Chen Z and He J: Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway. J Exp Clin Cancer Res. 36:542017. View Article : Google Scholar : PubMed/NCBI | |
|
Xu L, Liu W, Li T, Hu Y, Wang Y, Huang L, Wang Y, Shao S, Liu X and Zhan Q: Long non-coding RNA SMASR inhibits the EMT by negatively regulating TGF-β/Smad signaling pathway in lung cancer. Oncogene. 40:3578–3592. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Zhang G, Cheng Z, Dai L, Jia L, Jing X, Wang H, Zhang R, Liu M, Jiang T, et al: Knockdown of LncRNA-XIST suppresses proliferation and TGF-β1-induced EMT in NSCLC through the Notch-1 pathway by regulation of miR-137. Genet Test Mol Biomarkers. 220:333–342. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ni J, Zhang X, Li J, Zheng Z, Zhang J, Zhao W and Liu L: Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts. Cell Death Dis. 12:6622021. View Article : Google Scholar : PubMed/NCBI | |
|
Shi J, Li J, Yang S, Hu X, Chen J, Feng J, Shi T, He Y, Mei Z, He W, et al: LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway. J Cell Physiol. 235:2891–2900. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu L, Liu Y, Tang H and Wang P: FOXP3 activated-LINC01232 accelerates the stemness of non-small cell lung carcinoma by activating TGF-β signaling pathway and recruiting IGF2BP2 to stabilize TGFBR1. Exp Cell Res. 413:1130242022. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Z, Li Y, Che Y, Huang J, Sun S, Mao S, Lei Y, Li N, Sun N and He J: The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling. Cancer Lett. 432:156–168. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang L, Wang R, Fang L, Ge X, Chen L, Zhou M, Zhou Y, Xiong W, Hu Y, Tang X, et al: HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis. Theranostics. 9:2460–2474. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Gao H and Li Y: Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway. Mol Cell Endocrinol. 500:1106342020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao JJ, Hao S, Wang LL, Hu CY, Zhang S, Guo LJ, Zhang G, Gao B, Jiang Y, Tian WG and Luo DL: Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway. Oncotarget. 7:57903–57918. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou H, Sun Z, Li S, Wang X and Zhou X: LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer. Cancer Gene Ther. 25:39–46. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ju W, Luo X and Zhang N: LncRNA NEF inhibits migration and invasion of HPV-negative cervical squamous cell carcinoma by inhibiting TGF-β pathway. Biosci Rep. 39:BSR201808782019. View Article : Google Scholar : PubMed/NCBI | |
|
Cao L, Jin H, Zheng Y, Mao Y, Fu Z, Li X and Dong L: DANCR-mediated microRNA-665 regulates proliferation and metastasis of cervical cancer through the ERK/SMAD pathway. Cancer Sci. 110:913–925. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Feng S, Liu W, Bai X, Pan W, Jia Z, Zhang S, Zhu Y and Tan W: LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer. Cancer Lett. 465:105–117. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Mao S, Jin J, Li Z and Yang W: Knockdown of long non-coding RNA ANRIL inhibits the proliferation and promotes the apoptosis of Burkitt lymphoma cells through the TGF-β1 signaling pathway. Mol Med Rep. 23:1462021. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Liu H, Zhong Q, Wu J and Tang Z: LncRNA UCA1 is necessary for TGF-β-induced epithelial-mesenchymal transition and stemness via acting as a ceRNA for Slug in glioma cells. FEBS Open Bio. 8:1855–1865. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Li M, Xia P, Wang L and Lu Z: Targeting long non-coding RNA PVT1/TGF-β/Smad by p53 prevents glioma progression. Cancer Biol Ther. 23:225–233. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Ma J, Kong FF, Yang D, Yang H, Wang C, Cong R and Ma XX: lncRNA MIR210HG promotes the progression of endometrial cancer by sponging miR-337-3p/137 via the HMGA2-TGF-β/Wnt pathway. Mol Ther Nucleic Acids. 24:905–922. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Weng W, Liu C, Li G, Ruan Q, Li H, Lin N and Chen G: Long non-coding RNA SNHG16 functions as a tumor activator by sponging miR-373-3p to regulate the TGF-β-R2/SMAD pathway in prostate cancer. Mol Med Rep. 24:8432021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Feng W, Zhang J, Ge L, Zhang Y, Jiang X, Peng W, Wang D, Gong A and Xu M: Long non-coding RNA PVT1 promotes epithelial-mesenchymal transition via the TGF-β/Smad pathway in pancreatic cancer cells. Oncol Rep. 40:1093–1102. 2018.PubMed/NCBI | |
|
Papoutsoglou P, Rodrigues-Junior DM, Morén A, Bergman A, Pontén F, Coulouarn C, Caja L, Heldin CH and Moustakas A: The noncoding MIR100HG RNA enhances the autocrine function of transforming growth factor β signaling. Oncogene. 40:3748–3765. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou B, Guo W, Sun C, Zhang B and Zheng F: Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway. Cell Death Dis. 9:7062018. View Article : Google Scholar : PubMed/NCBI | |
|
Wu Y, Gu W, Han X and Jin Z: LncRNA PVT1 promotes the progression of ovarian cancer by activating TGF-β pathway via miR-148a-3p/AGO1 axis. J Cell Mol Med. 25:8229–8243. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Huang P, Qi B, Yao H, Zhang L, Li Y and Li Q: Knockdown of DANCR suppressed the biological behaviors of ovarian cancer cells treated with transforming growth factor-β (TGF-β) by sponging MiR-214. Med Sci Monit. 26:e9227602020. View Article : Google Scholar : PubMed/NCBI | |
|
Shi H, Xie J, Wang K, Li W, Yin L, Wang G, Wu Z, Ni J, Mao W, Guo C and Peng B: LINC01451 drives epithelial-mesenchymal transition and progression in bladder cancer cells via LIN28/TGF-β/Smad pathway. Cell Signal. 81:1099322021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhuang J, Shen L, Yang L, Huang X, Lu Q, Cui Y, Zheng X, Zhao X, Zhang D, Huang R, et al: TGFβ1 promotes gemcitabine resistance through regulating the LncRNA-LET/NF90/miR-145 signaling axis in bladder cancer. Theranostics. 7:3053–3067. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng C, Li R, Zheng S, Fang H, Xu M and Zhong L: LINC00174 facilitates cell proliferation, cell migration and tumor growth of osteosarcoma regulating the TGF-β/SMAD signaling pathway and upregulating SSH2 expression. Front Mol Biosci. 8:6977732021. View Article : Google Scholar : PubMed/NCBI | |
|
Huarte M: The emerging role of lncRNAs in cancer. Nat Med. 21:1253–1261. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Tzavlaki K and Moustakas A: TGF-β signaling. Biomolecules. 10:4872020. View Article : Google Scholar : PubMed/NCBI | |
|
Lai XN, Li J, Tang LB, Chen WT, Zhang L and Xiong LX: MiRNAs and LncRNAs: Dual roles in TGF-β signaling-regulated metastasis in lung cancer. Int J Mol Sci. 21:11932020. View Article : Google Scholar : PubMed/NCBI | |
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F and Liu Y: TGF-β-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res. 20:1531–1541. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang M, Weng W, Zhang Q, Wu Y, Ni S, Tan C, Xu M, Sun H, Liu C, Wei P and Du X: The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5. J Hematol Oncol. 11:1132018. View Article : Google Scholar : PubMed/NCBI | |
|
Tao S, Chen Q, Lin C and Dong H: Linc00514 promotes breast cancer metastasis and M2 polarization of tumor-associated macrophages via Jagged1-mediated notch signaling pathway. J Exp Clin Cancer Res. 39:1912020. View Article : Google Scholar : PubMed/NCBI | |
|
Akbari A, Ghahremani MH, Mobini GR, Abastabar M, Akhtari J, Bolhassani M and Heidari M: Down-regulation of miR-135b in colon adenocarcinoma induced by a TGF-β receptor I kinase inhibitor (SD-208). Iran J Basic Med Sci. 18:856–861. 2015.PubMed/NCBI | |
|
Han S, Bui NT, Ho MT, Kim YM, Cho M and Shin DB: Dexamethasone inhibits TGF-β1-induced cell migration by regulating the ERK and AKT pathways in human colon cancer cells via CYR61. Cancer Res Treat. 48:1141–1153. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Koelink PJ, Hawinkels LJAC, Wiercinska E, Sier CF, Ten Dijke P, Lamers CB, Hommes DW and Verspaget HW: 5-Aminosalicylic acid inhibits TGF-beta1 signalling in colorectal cancer cells. Cancer Lett. 287:82–90. 2010. View Article : Google Scholar : PubMed/NCBI |
